Agilon Health (NYSE:AGL) Trading Down 5% – Time to Sell?

Shares of Agilon Health, Inc. (NYSE:AGL) fell 5% during trading on Monday . The stock traded as low as $121.65 and last traded at $123.2930. Approximately 59,013 shares traded hands during trading, a decline of 83% from the average daily volume of 349,783 shares. The stock had previously closed at $129.84.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Wells Fargo & Company reiterated an “overweight” rating and set a $141.00 target price (up from $72.00) on shares of Agilon Health in a research report on Monday, July 13th. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price target for the company in a report on Tuesday, May 26th. Benchmark reaffirmed a “buy” rating and issued a $95.00 price target (up from $13.00) on shares of Agilon Health in a research note on Thursday, May 21st. TD Cowen reiterated a “hold” rating and set a $55.00 price objective (up from $17.00) on shares of Agilon Health in a report on Monday, May 11th. Finally, JPMorgan Chase & Co. cut shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price objective on the stock. in a research report on Monday, May 4th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $64.00.

Agilon Health Stock Performance

The company’s fifty day moving average price is $103.25 and its 200 day moving average price is $49.25. The company has a market cap of $2.10 billion, a PE ratio of -5.84 and a beta of 2.98. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.04 and a quick ratio of 1.04.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.04 by $0.76. The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. On average, equities research analysts predict that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Institutional Trading of Agilon Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. LPL Financial LLC boosted its position in Agilon Health by 213.4% in the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after purchasing an additional 30,000 shares during the last quarter. Krilogy Financial LLC purchased a new stake in shares of Agilon Health during the 4th quarter valued at $34,000. CIBC Bancorp USA Inc. bought a new stake in shares of Agilon Health during the 3rd quarter worth $34,000. Merit Financial Group LLC purchased a new position in shares of Agilon Health in the 4th quarter worth about $35,000. Finally, Focus Partners Advisor Solutions LLC bought a new position in Agilon Health during the fourth quarter valued at about $53,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.